Financial News
All news about Sanofi-Aventis S.A.
From Benzinga
Sanofi Keeps Sliding, Watch This Trade Level
October 07, 2020
From Blogs - TalkMarkets
This Healthcare Stock Could Keep Crushing the Market
October 06, 2020
From Motley Fool
Why Is Everyone Talking About Novavax Stock?
October 06, 2020
From Motley Fool
Will Big Pharma Acquire Novavax?
October 03, 2020
From Motley Fool
The Daily Biotech Pulse: Mesoblast Slumps On FDA Rejection, AstraZeneca's Breakthrough Therapy Designation, 3 IPOs
October 02, 2020
From Benzinga
As Trump says he is positive for coronavirus, a look back at his shifting statements on face masks and the severity of COVID-19
October 02, 2020
From MarketWatch
EmergingGrowth.com Reports on Why Galectin Therapeutics is Due for a COVID-19 Makeover
September 29, 2020
From iCrowdNewswire
EmergingGrowth.com Reports on Why Galectin Therapeutics (GALT) is Due for a COVID-19 Makeover
September 29, 2020
From EIN Presswire
There are four coronavirus vaccines in late-stage studies; here’s how they differ
September 25, 2020
From MarketWatch
Sanofi CEO Says COVID-19 Vaccine Development Process Accelerated, Not Side-Stepped
September 25, 2020
From Benzinga
Current Updates On COVID-19 Vaccine
September 24, 2020
From Benzinga
Gilead Settles US Kickback Allegations For $97M
September 24, 2020
From Benzinga
Playboy Reportedly In Talks For SPAC Merger Targeting Erectile Dysfunction Market
September 23, 2020
From Benzinga
Everything you need to know about what it would take for the FDA to approve a COVID-19 vaccine
September 22, 2020
From MarketWatch
Initial data from a pair of clinical trials may revive interest in arthritis drugs as COVID-19 treatments
September 18, 2020
From MarketWatch
Coronavirus update: Global case tally tops 30 million, and controversial CDC testing guideline changes were reportedly not made by CDC scientists
September 18, 2020
From MarketWatch
Sanofi: Debt Insights
September 18, 2020
From Benzinga
Is AstraZeneca Still A Safe Bet?
September 17, 2020
From Benzinga
Checkpoint Therapeutics To Release Significant Drug Data At This Week's ESMO Congress
September 14, 2020
From Benzinga
Is Novavax Stock a Buy?
September 13, 2020
From Motley Fool
(PRNB) Alert: Johnson Fistel Investigates Proposed Sale of Principia Biopharma; Is $100 a Fair Price?
September 12, 2020
From PR Newswire
From Motley Fool
Why Shares of Moderna Rose While the Market Tanked on Thursday
September 10, 2020
From Motley Fool
2 Game-Changing Biotech Stocks That May Make You Rich
September 10, 2020
From Motley Fool
3 Compelling Reasons to Buy Novavax Right Now
September 10, 2020
From Motley Fool
The Daily Biotech Pulse: AstraZeneca Pauses Coronavirus Vaccine Study, Trillium To Get $25M Pfizer Investment
September 09, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
